Acquisition method (AMC)
3
FSC 6505 × ADENOVIRUS TYPE 4 AND TYPE 7 VAC
ADENOVIRUS TYPE 4 AND TYPE 7 VAC
6505-01-642-0106 FSC 6505
NSN 6505-01-642-0106 (also written 6505016420106; NIIN 01-642-0106) is an adenovirus type 4 and type 7 vac in Federal Supply Class 6505, Drugs and Biologicals. 4 manufacturer part numbers from 4 suppliers are on record. It was last purchased in Sep 2026.
Open for bid
No open solicitations on record for this NSN right now.
Can you win it?
This item is coded to be bought directly from the actual manufacturer (AMC 3).
Suffix (AMSC)
Z
Competition
Coded for a named source
AMC 3: buy directly from the actual manufacturer, second or later time. AMSC Z: a commercial, nondevelopmental or off-the-shelf item. The codes describe the item's status on record, not any one solicitation. What the codes mean
What it is — can you make it?
Dimensions, the FLIS specification requirements, and the manufacturer part numbers already qualified against this NSN.
Specifications
From the federal catalog (DLA FLIS / PUB LOG) — what your part has to meet. Cited specification documents can be looked up in ASSIST Quick Search ↗, DoD's public spec repository — copy the document number in.
| Requirement | Value |
|---|---|
| PART NAME ASSIGNED BY CONTROLLING AGENCY CXCY | ADENOVIRUS TYPE 4 AND TYPE 7 VACCINE LIVE ORAL ENTERIC COATED TABLETS 200S |
| SPECIAL FEATURES FEAT | CONTAINS VIABLE, SELECTED STRAINS OF HUMAN ADENOVIRUS TYPE 4 AND HUMAN ADENOVIRUS TYPE 7 PREPARED IN HUMAN-DIPLOID FIBROBLAST CELL CULTURES (STRAIN WI-38); VIRUS STRAINS HAVE NOT BEEN ATTENUATED; CELLS ARE GROWN AND THE VIRUS GROWTH MAINTAINED IN DULBECCO'S MODIFIED EAGLE'S MEDIUM, FETAL BOVINE SERUM, AND SODIUM BICARBONATE; APPROVED FOR USE IN MILITARY POPULATIONS 17-50 YEARS OF AGE; INDICATED FOR ACTIVE IMMUNIZATION FOR THE PREVENTION OF FEBRILE ACUTE RESPIRATORY DISEASE CAUSED BY ADENOVIRUS TYPE 4 AND TYPE 7; CARTON CONSISTS OF ONE BOTTLE OF 100 TABLETS ADENOVIRUS TYPE 4 (NDC 51285-174-02) AND ONE BOTTLE OF 100 TABLETS ADENOVIRUS TYPE 7 (NDC 51285-175-02); STORE REFRIGERATED BETWEEN 2-8 DEG C (35-46 DEG F); DO NOT FREEZE; KEEP BOTTLE TIGHTLY CLOSED AND PROTECT FROM MOISTURE; DO NOT REMOVE DESICCANT CANISTER FROM BOTTLE; PRESCRIPTION ONLY; FOR ORAL ADMINISTRATION; DOSAGE: ONE TABLET OF ADENOVIRUS TYPE 4 COMPONENT AND ONE TABLET OF ADENOVIRUS TYPE 7 COMPONENT |
Manufacturer part numbers
Commercial part numbers cross-referenced to this NSN in the federal catalog — the parts that have been accepted as satisfying this stock number, and who makes them.
| Part number | CAGE | Manufacturer |
|---|---|---|
| 1281637 | 89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA |
| 6505NCM151649 | 64616 | DEFENSE MEDICAL STANDARDIZATION BOARD |
| NDC51285-0138-50 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
| NDC51285-0138-50 | 56490 | BARR LABORATORIES, INC. DBA BARR LABORATORIES, INC INC |
What it pays — so you can quote
The government's own price and demand record for this NSN — what past awards cleared at, so you know where to land your quote.
Latest unit price
—
Purchases
0
Total spend
—
Sep 16, 2026
Last purchased
15 · 15.0/yr
Purchase records
$6,870,528
Total demand
$515,290
Latest award total
Purchase history
No priced purchases on record for this NSN yet.
Related contract actions
Contract action totals, not unit prices — obligation amounts from USAspending for related awards, shown for context only. These do not appear on the price chart above.
| Action date | Award # | Recipient | Agency | Obligation |
|---|---|---|---|---|
| Aug 12, 2026 | SPE2DP20D0002/SPE2DP26F8916 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $171,763 |
| Aug 12, 2026 | SPE2DP20D0002/SPE2DP26F8915 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $343,526 |
| Aug 12, 2026 | SPE2DP20D0002/SPE2DP26F8914 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $515,290 |
| Aug 12, 2026 | SPE2DP20D0002/SPE2DP26F8913 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $687,053 |
| Aug 12, 2026 | SPE2DP20D0002/SPE2DP26F8912 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $343,526 |
| Aug 12, 2026 | SPE2DP20D0002/SPE2DP26F8911 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $343,526 |
| Aug 12, 2026 | SPE2DP20D0002/SPE2DP26F8910 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $1,030,579 |
| Aug 12, 2026 | SPE2DP20D0002/SPE2DP26F8909 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $515,290 |
| Sep 16, 2026 | SPE2DP20D0002/SPE2DP26F9980 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $171,763 |
| Sep 16, 2026 | SPE2DP20D0002/SPE2DP26F9977 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $343,526 |
| Sep 16, 2026 | SPE2DP20D0002/SPE2DP26F9976 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $343,526 |
| Sep 16, 2026 | SPE2DP20D0002/SPE2DP26F9975 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $515,290 |
| Sep 16, 2026 | SPE2DP20D0002/SPE2DP26F9974 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $687,053 |
| Sep 16, 2026 | SPE2DP20D0002/SPE2DP26F9973 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $343,526 |
| Sep 16, 2026 | SPE2DP20D0002/SPE2DP26F9971 ↗ | TEVA PHARMACEUTICALS USA, INC. | — | $515,290 |
Demand history
Who wins this item
Does one supplier win this every time, and are the winners on the listed-source list? One dot per award.
- Award in the last 2 years
- Older award
TEVA PHARMACEUTICALS USA, INC.
last award Sep 2026
+3
Listed source BARR LABORATORIES, INC. DBA BARR LABORATORIES, INC INC
no award yet
no awards on record
Listed source DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
no award yet
no awards on record
Listed source DEFENSE MEDICAL STANDARDIZATION BOARD
no award yet
no awards on record
Listed source TEVA PHARMACEUTICALS USA, INC. won 10 of the last 10 awards.
Open RFQs on DIBBS → DIBBS award history ↗
About this data
- Unit prices: DLA DIBBS award records — every row links to its government record.
- AMSC: latest observed value from DIBBS solicitation history as of Oct 20, 2026.
- Contract action totals: USAspending, context only.
- Data last refreshed: 2026-11-04.
- Full methodology →
Cite this page
Citation
NSN Explorer. "ADENOVIRUS TYPE 4 AND TYPE 7 VAC." nsnexplorer.com, https://nsnexplorer.com/nsn/6505-01-642-0106/. Data as of November 7, 2026.
Link
https://nsnexplorer.com/nsn/6505-01-642-0106/